NFKB1 and atherosclerosis: To test whether endothelial cell Cdc42 deletion also inhibited chronic inflammation in a mouse model of atherosclerosis, we used apolipoprotein E knockout (Apoe KO) mice in which atherosclerotic plaque formation was enhanced by endothelial NF-κB signaling [27].